Cargando…
Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial
This double-blind, randomized, placebo/controlled, crossover study evaluated the efficacy of Eriomin(®) in reducing hyperglycemia and improving diabetes-related biomarkers in individuals with hyperglycemia above 110 mg/dL (mean 123 ± 18 mg/dL). Subjects (n = 30), divided into two groups (Eriomin or...
Autores principales: | Cesar, Thais Borges, Ramos, Fernanda Maria Manzini, Ribeiro, Carolina Barbosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700344/ https://www.ncbi.nlm.nih.gov/pubmed/35796695 http://dx.doi.org/10.1089/jmf.2021.0181 |
Ejemplares similares
-
Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double‐blind, randomized, controlled study
por: Ribeiro, Carolina B., et al.
Publicado: (2019) -
Lemon flavonoids nutraceutical (Eriomin®) attenuates prediabetes intestinal dysbiosis: A double‐blind randomized controlled trial
por: Ramos, Fernanda M. M., et al.
Publicado: (2023) -
Exploring the Association between Citrus Nutraceutical Eriocitrin and Metformin for Improving Pre-Diabetes in a Dynamic Microbiome Model
por: Cesar, Thais, et al.
Publicado: (2023) -
Metabolism of eriocitrin in the gut and its regulation on gut microbiota in mice
por: Meng, Xia, et al.
Publicado: (2023) -
Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis
por: Hiramitsu, Masanori, et al.
Publicado: (2014)